Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic CancerMOLECULAR CANCER THERAPEUTICSIF5.52017-05-0286OAAI
Hepatitis B Virus Immunopathology, Model Systems, and Current TherapiesFRONTIERS IN IMMUNOLOGYIF5.92017-04-1324OAAI
The dual Rac/Cdc42 inhibitor EHop-167 as a breast cancer therapeuticEUROPEAN JOURNAL OF CANCERIF7.12016-12-010PREAI
Characterization of an improved derivative of the Rac/PAK inhibitor EHop-016 in breast cancerCANCER RESEARCHIF16.62016-07-150PRE
The Rac and PAK inhibitor EHop-016 inhibits mammary tumor growth and metastasis in a nude mouse model.MOLECULAR CANCER THERAPEUTICSIF5.52013-11-010PRE
Characterization of EHop-016, Novel Small Molecule Inhibitor of Rac GTPaseJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92012-04-01210OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向